Trial Profile
Safety, Activity, and Pharmacology of Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 10 Sep 2018 New trial record